(Washington, DC – October 7, 2014) – The American College of Cardiology has appointed Galileo Analytics Co-Founder Anna McCollister-Slipp to serve on the Stakeholder Advisory Panel of its newly created Diabetes Collaborative Registry.
The Diabetes Collaborative Registry™ is the first global, cross-specialty, clinical diabetes registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum.
The American College of Cardiology (ACC) and AstraZeneca, in partnership with the American Diabetes Association, American College of Physicians, and the Joslin Diabetes Center have joined forces to integrate compelling, data-rich assets to provide a unique, longitudinal view into the patient journey for those with diabetes and, ultimately, one day be able to transform the future of diabetes care.
The unique, real-world collaboration among multi-disciplinary providers is designed to help transform the future of diabetes treatment and prevention and improve the lives of billions.
The Stakeholder Advisory Panel panel includes representatives from physician organizations, academic researchers, advocacy groups, data analytics experts and diabetes patients. Panel members include:
William J. Oetgen, M.D., M.B.A., F.A.C.C., American College of Cardiology
Jane L. Chiang, M.D. , American Diabetes Association
Laura Lee Hall, Ph.D. , American College of Physicians
Catherine Carver, M.S., A.N.P., C.D.E., Joslin Diabetes Center
Anna McCollister-Slipp, Galileo Analytics
Gregory A. Nichols, Ph.D., M.B.A., F.A.H.A., Kaiser Permanente Center for Health Research
John W. Kennedy, M.D., Geisinger Health System
David C. Klonoff, M.D., F.A.C.P., F.R.C.P (Edin), Fellow AIMBE, Mills-Peninsula Health Services, Journal of Diabetes Science & Technology
Gary Puckrein, Ph.D., National Minority Quality Forum
Brian Anderson, M.D., athenaHealth
Jennifer Covich Bordenick, eHealth Initiative
Sandra Leonard, M.P.H., AstraZeneca
Javier Jimenez, M.D., M.P.H., AstraZeneca
William S. Cook, Ph.D., AstraZeneca
Iftekhar Kalsekhar, Ph.D., AstraZeneca
Mikhail Kosiborod, M.D., F.A.C.C., F.A.H.A., Saint Luke’s Mid America Heart Institute
Silvio Inzucchi, M.D., Yale Diabetes Center
Jennifer L. Wong, M.P.P., American College of Cardiology
More information about the Diabetes Collaborative Registry can be found at http://www.ncdr.com.
###
